Cytox Release: Role Of mTOR Pathway As A Marker Of Risk In Alzheimer’s Disease To Be Presented At AAIC 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cytox, a leading developer of assays for risk assessment and prediction of dementia, announced the timing of a presentation discussing the development of a novel proprietary blood-based assay for the assessment of risk of cognitive decline.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC